This report summarises Australia's spontaneous surveillance data for non-COVID-19 vaccine adverse events following immunisation (AEFI) for 2022, reported to the Therapeutic Goods Administration (TGA). National spontaneous (passive) surveillance data for coronavirus disease 2019 (COVID-19) vaccine AEFI reported to the TGA are analysed and discussed in a separate companion publication. There were 3,642 AEFI reports for non-COVID-19 vaccines administered in 2022, representing an annual AEFI reporting rate of 14.0 per 100,000 population, compared with 13.4 per 100,000 population in 2021. This very small increase in the AEFI reporting rate in 2022 could potentially be related to the combination of several factors: a gradual return to pre-pandemic AEFI reporting patterns; new vaccination programs in response to outbreaks of emergent vaccine preventable diseases (Japanese encephalitis and mpox); and a change in the reporting activities of pharmaceutical sponsors. AEFI reporting rates for individual vaccines in 2022 were similar to 2021.
Keywords: AEFI; adverse events; immunisation; surveillance; vaccine; vaccines.
© Commonwealth of Australia CC BY-NC-ND.